Synaptotagmin XI as a candidate gene for susceptibility to schizophrenia

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 144, Issue 3, 2007, Pages 332-340

  Inoue, Shinichi ^a,g   Imamura, Aldira ^b   Okazaki, Yuji ^c   Yokota, Hiroshi ^d   Arai, Makoto ^e   Hayashi, Naoki ^e,f   Furakawa, Aizo ^e   Itokawa, Masanari ^e   Oishi, Michio ^a  

^a Kazusa DNA Research Institutes   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d DAIICHI SANKYO CO   (Japan)

^e TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^f TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

^g NONE   (Japan)

Author keywords

Repeat expansion; Schizophrenia; SP1; YY1

Indexed keywords

SYNAPTOTAGMIN; SYNAPTOTAGMIN XI; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR YY1; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ARTICLE; CHROMOSOME 1Q; CONTROLLED STUDY; GENE; GENE EXPRESSION REGULATION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SYT11 GENE; TRANSCRIPTION REGULATION;

EID: 34247334943     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30465     Document Type: Article

References (32)

1. Andrews NC, Erdjument-Bromage H, Davidson MB, Tempst P, Orkin SH. 1993. Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature 362(6422):722-728.
2. Briggs MR, Kadonaga JT, Bell SP, Tjian R. 1986. Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science 234(4772):47-52.
3. Brzustowicz LM, Hodgkinson KA, Chow EW, Honer WG, Bassett AS. 2000. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 288(5466):678-682.
4. Brzustowicz LM, Simone J, Mohseni P, Hayter JE, Hodgkinson KA, Chow EW, Bassett AS. 2004. Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22. Am J Hum Genet 74(5):1057-1063.
5. Chandy KG, Fantino E, Wittekindt O, Kalman K, Tong LL, Ho TH, Gutman GA, Crocq MA, Ganguli R, Nimgaonkar V, et al. 1998. Isolation of a novel potassium channel gene hSKCa3 containing a polymorphic CAG repeat: A candidate for schizophrenia and bipolar disorder? Mol Psychiatry 3(1):32-37.
6. Ferguson GD, Vician L, Herschman HR. 2001. Synaptotagmin IV: Biochemistry, genetics, behavior, and possible links to human psychiatric disease. Mol Neurobiol 23(2-3):173-185.
7. Fukuda M. 2003. Molecular cloning and characterization of human, rat, and mouse synaptotagmin XV. Biochem Biophys Res Commun 306(1):64-71.
8. Glass AS, Huynh DP, Franck T, Woitalla D, Muller T, Pulst SM, Berg D, Kruger R, Riess O. 2004. Screening for mutations in synaptotagmin XI in Parkinson's disease. J Neural Transm Suppl 68: 21-28.
9. Hagen G, Muller S, Beato M, Suske G. 1992. Cloning by recognition site screening of two novel GT box binding proteins: A family of Sp1 related genes. Nucleic Acids Res 20(21):5519-5525.
10. Harrison PJ, Weinberger DR. 2005. Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Mol Psychiatry 10(1):40-68; image 5.
11. Huynh DP, Scoles DR, Nguyen D, Pulst SM. 2003. The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. Hum Mol Genet 12(20):2587-2597.
12. Inoue S, Oishi M. 2005. Effects of methylation of non-CpG sequence in the promoter region on the expression of human synaptotagmin XI (syt11). Gene 348:123-134.
13. Kirov G, O'Donovan MC, Owen MJ. 2005. Finding schizophrenia genes. J Clin Invest 115(6):1440-1448.
14. Kontkanen O, Toronen P, Lakso M, Wong G, Castren E. 2002. Antipsychotic drug treatment induces differential gene expression in the rat cortex. J Neurochem 83(5):1043-1053.
15. Lee JS, Galvin KM, Shi Y. 1993. Evidence for physical interaction between the zinc-finger transcription factors YY1 and Sp1. Proc Natl Acad Sci U S A 90(13):6145-6149.
16. Mermod N, Williams TJ, Tjian R. 1988. Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro. Nature 332(6164):557-561.
17. Mimics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P. 2001. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry 6(3):293-301.
18. Morris JF, Hromas R, Rauscher FJ, III. 1994. Characterization of the DNA-binding properties of the myeloid zinc finger protein MZF1: Two independent DNA-binding domains recognize two DNA consensus sequences with a common G-rich core. Mol Cell Biol 14(3):1786-1795.
19. Nagase T, Kikuno R, Ohara O. 2003. The Kazusa cDNA project for identification of unknown human transcripts. C R Biol 326(10-11): 959-966.
20. Ohara O, Nagase T, Ishikawa K, Nakajima D, Ohira M, Seki N, Nomura N. 1997. Construction and characterization of human brain cDNA libraries suitable for analysis of cDNA clones encoding relatively large proteins. DNA Res 4(1):53-59.
21. Paulson L, Martin P, Persson A, Nilsson CL, Ljung E, Westman-Brinkmalm A, Eriksson PS, Blennow K, Davidsson P. 2003. Comparative genome-and proteome analysis of cerebral cortex from MK-801-treated rats. J Neurosci Res 71(4):526-533.
22. Roman DG, Toledano MB, Leonard WJ. 1990. Sp1 represses IL-2 receptor alpha chain gene expression. New Biol 2(7):642-647.
23. Sekido R, Murai K, Funahashi J, Kamachi Y, Fujisawa-Sehara A, Nabeshima Y, Kondoh H. 1994. The delta-crystallin enhancer-binding protein delta EF1 is a repressor of E2-box-mediated gene activation. Mol Cell Biol 14(9):5692-5700.
24. Seto E, Shi Y, Shenk T. 1991. YY1 is an initiator sequence-binding protein that directs and activates transcription in vitro. Nature 354(6350):241-245.
25. Seto E, Lewis B, Shenk T. 1993. Interaction between transcription factors Sp1 and YY1. Nature 365(6445):462-464.
26. Shi Y, Seto E, Chang LS, Shenk T. 1991. Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein. Cell 67(2):377-388.
27. Shrivastava A, Calame K. 1994. An analysis of genes regulated by the multi-functional transcriptional regulator Yin Yang-1. Nucleic Acids Res 22(24):5151-5155.
28. Sudhof TC. 2002. Synaptotagmins: Why so many? J Biol Chem 277(10): 7629-7632.
29. Suske G. 1999. The Sp-family of transcription factors. Gene 238(2):291-300.
30. Thomas MJ, Seto E. 1999. Unlocking the mechanisms of transcription factor YY1: Are chromatin modifying enzymes the key? Gene 236(2):197-208.
31. Yokota H, Tsujita T, Okazaki Y, Kikuya E, Oishi M. 2003. Polymorphic 33-bp repeats with promoter-like activity in synaptotagmin 11 gene. DNA Res 10(6):287-289.
32. Yoshihara M, Adolfsen B, Littleton JT. 2003. Is synaptotagmin the calcium sensor? Curr Opin Neurobiol 13(3):315-323.